Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of RAC1-driven malignant melanoma by group A PAK inhibitors
Authors
Keywords
-
Journal
ONCOGENE
Volume 37, Issue 7, Pages 944-952
Publisher
Springer Nature
Online
2017-10-24
DOI
10.1038/onc.2017.400
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- RASopathy Gene Mutations in Melanoma
- (2016) Ruth Halaban et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- RAC1 and Melanoma
- (2015) Ruth Halaban CLINICAL THERAPEUTICS
- RASopathies: unraveling mechanisms with animal models
- (2015) G. A. Jindal et al. Disease Models & Mechanisms
- Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
- (2015) Michael Krauthammer et al. NATURE GENETICS
- RAC1 P29S regulates PD-L1 expression in melanoma
- (2015) Ha Linh Vu et al. Pigment Cell & Melanoma Research
- Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
- (2014) Xiaodong Feng et al. CANCER CELL
- The RAC1 P29S Hotspot Mutation in Melanoma Confers Resistance to Pharmacological Inhibition of RAF
- (2014) Ian R. Watson et al. CANCER RESEARCH
- RAS and RHO Families of GTPases Directly Regulate Distinct Phosphoinositide 3-Kinase Isoforms
- (2013) Ralph Fritsch et al. CELL
- P21-Activated Kinase 1 (PAK1) as a Therapeutic Target in BRAF Wild-Type Melanoma
- (2013) Christy C. Ong et al. JNCI-Journal of the National Cancer Institute
- Transforming mutations of RAC guanosine triphosphatases in human cancers
- (2013) M. Kawazu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RAC1P29S is a spontaneously activating cancer-associated GTPase
- (2013) M. J. Davis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p21-Activated Kinase 1 Is Required for Efficient Tumor Formation and Progression in a Ras-Mediated Skin Cancer Model
- (2012) H. Y. Chow et al. CANCER RESEARCH
- A Landscape of Driver Mutations in Melanoma
- (2012) Eran Hodis et al. CELL
- Continual low-level MEK inhibition ameliorates cardio-facio-cutaneous phenotypes in zebrafish
- (2012) C. Anastasaki et al. Disease Models & Mechanisms
- Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
- (2012) Michael Krauthammer et al. NATURE GENETICS
- Comparative Analysis of Dynamic Cell Viability, Migration and Invasion Assessments by Novel Real-Time Technology and Classic Endpoint Assays
- (2012) Ridha Limame et al. PLoS One
- Rac1 Drives Melanoblast Organization during Mouse Development by Orchestrating Pseudopod- Driven Motility and Cell-Cycle Progression
- (2011) Ang Li et al. DEVELOPMENTAL CELL
- P-Rex1 is required for efficient melanoblast migration and melanoma metastasis
- (2011) Colin R. Lindsay et al. Nature Communications
- Kinase-activating and kinase-impaired cardio-facio-cutaneous syndrome alleles have activity during zebrafish development and are sensitive to small molecule inhibitors
- (2009) C. Anastasaki et al. HUMAN MOLECULAR GENETICS
- Emi1 Maintains Genomic Integrity during Zebrafish Embryogenesis and Cooperates with p53 in Tumor Suppression
- (2009) J. Rhodes et al. MOLECULAR AND CELLULAR BIOLOGY
- Interaction with LC8 Is Required for Pak1 Nuclear Import and Is Indispensable for Zebrafish Development
- (2009) Christine M. Lightcap et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started